International Publisher of Science, Technology and Medicine

 
 
Track Your Manuscript
 
 
 
 
Journal of Virology & Antiviral Research
Editor-in-chief: Jay C. Brown, PhD
University of Virginia Cancer Center, USA
ISSN: 2324-8955
Frequency: Quarterly
ICV Value: 5.79 
 
The Journal of Virology & Antiviral Research (JVA) promotes rigorous research that makes a significant contribution in advancing knowledge for Microbiology and Medicine. The journal includes all major themes pertaining to viral diseases and treatment.
 
Virology & Antiviral Research is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.
 
Current Issue
Editors & Editorial Board Members  
J Virol Antivir Res 2013, 2:4   
  PDF   
Prevalence of Hepatitis Virus and HBV/HCV Interactions in Opiate Addict Subjects   Research Article
Fabio Curcio and Clara Baldassarre
J Virol Antivir Res 2013, 2:4    doi: 10.4172/2324-8955.1000115
 Preview

Prevalence of Hepatitis Virus and HBV/HCV Interactions in Opiate Addict Subjects

Aims of the study were: 1) the assessment of the prevalence of HBV, HCV and HDV infections in opiate addict subjects; 2) the study of the viral interaction in vivo. Method: The study evaluated HBV and HCV infections in 1682 subjects assisted from 1990 to 2010. Outcomes: In 2010 the prevalence of HBV infection was of 42.3%; the number of HBs Ag carrier subjects was of 4,4%. HCV infection prevalence rose of 60.4%. The prevalence of the co-infection HBV/HCV was of 32.0%; during the co-infection phase, HBV infection spread earlier with a 2.8 higher probability than HCV infection. The RNA of HCV virus was positive in 25.9% of the cases of HBsAg carrier subjects. The RNA of HCV resulted to be positive among HBV infected subjects compared to HBV carrier subjects with O.R. 10.47.

|  Full Text |   PDF   
Herpes Simplex Virus Type-2 Infection and Associated Risk Factors among Weaver’s Community in Tamil Nadu State, India   Research Article
Sripriya M, Rajendran P, Seethalakshmi I, Murugesan K, Gnanasekaran AG, Kannan M and Kanthesh BM
J Virol Antivir Res 2013, 2:4    doi: 10.4172/2324-8955.1000116
 Preview

Herpes Simplex Virus Type-2 Infection and Associated Risk Factors among Weaver’s Community in Tamil Nadu State, India

Objective: To determine the presence of HSV-2 and its association to demographic and risk factors in the weavers population of Tamilnadu. Methods: 296 adults were surveyed in Kanchipuram, Erode and Tiruvannamalai districts of Tamil Nadu. Socio-demographic characteristics were obtained through interviews and 5 ml of blood was collected from individuals age 18 and over. Samples were tested for IgG anti HSV antibodies. The association between HSV- 2 infection and different behavioural variables was analysed using chi-square analysis.

|  Full Text |   PDF   
“To Treat or Not to Treat?”: A Case of Severe Acute Hepatitis-B Treated with Entecavir Compared to a Case of Milder, Untreated Disease   Case Report
Maria Francesca Zenobii, Stefano Ballestri, Amedeo Lonardo, Silvia Ognibene, Enrica Baldelli, Dante Romagnoli and Paola Loria
J Virol Antivir Res 2013, 2:4    doi: 10.4172/2324-8955.1000117
 Preview

“To Treat or Not to Treat?”: A Case of Severe Acute Hepatitis-B Treated with Entecavir Compared to a Case of Milder, Untreated Disease

Purpose: Acute hepatitis B, usually a benign disease in the immunocompetent adult, may be fatal in a minority of cases. The oral deoxyguanosine nucleoside analogue entecavir has gained a definite role in treating chronic hepatitis B virus infection. However, the indications and the specific timing for antiviral treatment in severe AHB remains to be established. We aimed at gaining insight into such indication based on clinical observation of two cases.

|  Full Text |   PDF